Skip to main content
Clinical Trials/CTRI/2017/09/009606
CTRI/2017/09/009606
Completed
未知

Evaluation of the effect of a standardized aqueous extract of Emblica officinalis on endothelial dysfunction and biomarkers of oxidative stress in metabolic syndrome subjects.

CGayatri Devi0 sites59 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Metabolic syndrome
Sponsor
CGayatri Devi
Enrollment
59
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 25, 2013
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
CGayatri Devi

Eligibility Criteria

Inclusion Criteria

  • Patients were of either gender, aged 30\-68 years, having endothelial dysfunction defined as \<\= 6% change in reflection index (RI) on post salbutamol challenge test and having metabolic syndrome.

Exclusion Criteria

  • Patients with severe uncontrolled hypertension, uncontrolled hyperglycemia, impaired hepatic or renal function, cardiac arrhythmia, history of smoking, chronic alcoholism, malignancy or stroke, any other serious disease requiring active treatment and treatment with any other herbal supplements

Outcomes

Primary Outcomes

Not specified

Similar Trials